Marie-Odile Joly
Overview
Explore the profile of Marie-Odile Joly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kientz C, Prieur F, Clemenson A, Joly M, Stachowicz M, Auclair J, et al.
Fam Cancer
. 2019 Nov;
19(1):11-14.
PMID: 31745674
Lynch syndrome accounts for 3-5% of colorectal cancers and is due to a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6, and PMS2. Somatic hypermethylation of...
2.
Kientz C, Joly M, Faivre L, Clemenson A, Dalac S, Lepage C, et al.
Hered Cancer Clin Pract
. 2017 May;
15:6.
PMID: 28507641
Background: The tumor spectrum in the Lynch syndrome is well defined, comprising an increased risk of developing colonic and extracolonic malignancies. Muir-Torre syndrome is a variant with a higher risk...
3.
Meyronet D, Esteban-Mader M, Bonnet C, Joly M, Uro-Coste E, Amiel-Benouaich A, et al.
Neuro Oncol
. 2017 Feb;
19(8):1127-1134.
PMID: 28201752
Background: Diffuse H3 K27M-mutant gliomas occur primarily in children but can also be encountered in adults. The aim of this study was to describe the characteristics of H3 K27M-mutant gliomas...
4.
Quillien V, Lavenu A, Ducray F, Joly M, Chinot O, Fina F, et al.
Oncotarget
. 2016 Aug;
7(38):61916-61929.
PMID: 27542245
Background: The goal of this prospective multicentric trial was to validate a technique that allowed for MGMT promoter methylation analysis in routine clinical practice. Methods: The MGMT status of 139...
5.
Marchand L, Nozieres C, Walter T, Descotes F, Decaussin-Petrucci M, Joly M, et al.
Acta Oncol
. 2016 May;
55(8):1064-6.
PMID: 27173015
No abstract available.
6.
Petronio M, Pinson S, Walter T, Joly M, Hervieu V, Forestier J, et al.
United European Gastroenterol J
. 2016 Apr;
4(2):305-13.
PMID: 27087961
Aim: The aim of this article is to clarify the epidemiologic, clinical, endoscopic, biological and genetic characteristics of type 1 serrated polyposis patients. Patients And Methods: Consecutive patients responding to...
7.
Bollard J, Massoma P, Vercherat C, Blanc M, Lepinasse F, Gadot N, et al.
Oncotarget
. 2015 Oct;
6(34):36731-45.
PMID: 26447612
Gastro-intestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, frequently metastatic, raising difficult clinical and therapeutic challenges due to a poor knowledge of their biology. As neuroendocrine cells express both epithelial and...
8.
Dussol A, Joly M, Vercherat C, Forestier J, Hervieu V, Scoazec J, et al.
Cancer
. 2015 Jun;
121(19):3428-34.
PMID: 26058464
Background: The alkylating agents (ALKYs) streptozotocin, dacarbazine, and temozolomide currently are the main drugs used in systemic chemotherapy for neuroendocrine tumors (NETs). The promising activity shown by gemcitabine and oxaliplatin...
9.
Joly M, Attignon V, Saurin J, Desseigne F, Leroux D, Martin-Denavit T, et al.
Hum Mutat
. 2014 Dec;
36(3):292-5.
PMID: 25504677
Sebaceous neoplasms are a major clinical feature of Muir-Torre syndrome (MTS) associated with visceral malignancies, especially colorectal and endometrial tumors. The diagnosis of MTS relies largely on the microsatellite instability...
10.
Nozieres C, Zhang C, Buffet A, Dupasquier S, Vargas-Poussou R, Guillaud-Bataille M, et al.
Ann Endocrinol (Paris)
. 2014 Jul;
75(3):133-40.
PMID: 24997771
Context: Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant inherited syndrome, related to mutations in the MEN1 gene. Controversial data suggest that the nonsynonymous p.Ala541Thr variant, usually considered...